Similar drugsTo uncover
Dosage form: & nbsp

capsules

Composition:

(per one capsule):

active ingredient: ginkgo biloba extract dry, standardized with the content of flavonol glycosides 22,0-27,0,0 % and terpene lactones 5.0-12.0% 0.040 g

auxiliary components: cellulose microcrystalline - 0.109 g, calcium stearate - 0.001 g, hard gelatin capsules (components of the capsule body: iron oxide black E 172, iron oxide red E 172, titanium dioxide E 171, iron oxide yellow E 172, gelatin capsule components: iron oxide black E 172, iron oxide red E 172, titanium dioxide E 171, iron oxide yellow E 172, gelatin).

Description:

Hard gelatin capsules from light brown to dark-brown color, size number 1.

The contents of the capsules are powder or partially crumpled powder from yellow to light brown

Pharmacotherapeutic group:Angioprotective agent of plant origin
ATX: & nbsp
  • Ginkgo Biloba Leaf Extract
  • Pharmacodynamics:Improves cerebral circulation and is equipped withoxygen and glucose. Has vasoregulatory effectson the vessels of the brain. Improves blood flow, inhibits thrombolysisoocytes. Prevents education free radicals.
    Indications:
    - disorders of cerebral circulation, accompanied by attention disorders, memory impairment, decreased intellectual abilities, dizziness, tinnitus, headache;
    - violations of peripheral circulation and microcirculation, accompanied by a feeling of cold in the limbs, pain during walking, painful cramps and heaviness in the legs, paresthesia;
    - violations of the inner ear, manifested by dizziness, unstable gait and noise in the ears.
    Contraindications:

    Hypersensitivity to components, decreased blood clotting, erosive gastritis, peptic ulcer disease and duodenum in the stage exacerbations, acute disorders of cerebral bloodration, pregnancy, lactation, children's age (up to 12 years) (due to lack ofm of sufficient number of clinical data).

    Dosing and Administration:

    If the doctor did not recommend another dosing regimen, adhere to the following recommendations for taking the drug:

    For symptomatic treatment of disorders of cerebral circulation:

    For 1-2 capsules (40-80 mg of standardized dry extract of ginkgo biloba respectively) 3 times a day. The duration of treatment is not less than 8 weeks.

    In cases of peripheral circulatory disorders:

    1 capsule (40 mg of standardized dry extract of ginkgo biloba, respectively) 3 times inday or 2 capsules (respectively 80 mg of standardized dry extract of ginkgo biloba) 2 times a day. The duration of the course of treatment is at least 6 weeks.

    In vascular or involuntary pathology of the inner ear: 1 capsule (40 mg of standardized dry extract of ginkgo biloba, respectively) 3 times a day or 2 capsules (respectively 80 mg of the standardized dry extract of ginkgo biloba) 2 times a day.

    Capsules should be taken with a small amount of liquid, regardless of food intake.

    If the drug was missed or if an insufficient amount was taken, it should be taken as described in this manual without any changes.
    Side effects:

    Allergic reactions are possible (redness, swelling of the skin, itching), dyspepsia, headache, decreased blood clotting, nhearing impairment, dizziness. If you observe any undesirablee phenomenon when taking the drug, please report them, please, to your doctor inrachu.

    Overdose:

    Cases of drug overdose have not been registered to date.

    Interaction:

    It is possible that the drug GINCOUM® with medicines, having an anticoagulant effect.

    Special instructions:

    Attention! All regulations must be strictly observedgive!

    In the event of sudden deterioration or loss of hearing you need to immediately apply to the doctor. A doctor's consultation is also necessaryand frequent dizziness and noise in ears.

    Form release / dosage:Capsules 40 mg.
    Packaging:

    For 15 capsules in a contour mesh package. By 2, 4, 6 contour mesh packages or each jar along with the instructions for use are placed in a cardboard pack.

    Storage conditions:
    At a temperature of no higher than 25 ° C, in the original packaging. In a place inaccessible to children.
    Shelf life:3 years.

    Do not use the drug after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-001576/08
    Date of registration:14.03.2008 / 16.12.2014
    Expiration Date:Unlimited
    The owner of the registration certificate:EVALAR, CJSC EVALAR, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp16.04.2017
    Illustrated instructions
      Instructions
      Up